462
Views
69
CrossRef citations to date
0
Altmetric
Review

Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease

, &
Pages 1647-1666 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wendy Noble, Amy M Pooler & Diane P Hanger. (2011) Advances in tau-based drug discovery. Expert Opinion on Drug Discovery 6:8, pages 797-810.
Read now

Articles from other publishers (68)

Xiaohua Wang, Xinli Chen, Fan Wu, Yingchao Liu, Yushen Yang, Weican Chen, Zhigang Pan, Weipeng Hu, Feng Zheng & Hefan He. (2023) Relationship between postoperative biomarkers of neuronal injury and postoperative cognitive dysfunction: A meta-analysis. PLOS ONE 18:4, pages e0284728.
Crossref
Yanfang Zhao, Yujin Gu, Qili Zhang, Hongliang Liu & Yingying Liu. (2023) The Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer’s Disease. Journal of Clinical Medicine 12:5, pages 1883.
Crossref
Jana Chudobová & Hans Zempel. (2023) Microtubule affinity regulating kinase (MARK/Par1) isoforms differentially regulate Alzheimer-like TAU missorting and Aβ-mediated synapse pathology. Neural Regeneration Research 18:2, pages 335.
Crossref
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, Ashley Selman, John Culberson & P. Hemachandra Reddy. (2022) Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies. International Journal of Molecular Sciences 23:21, pages 12841.
Crossref
Ibtissem Nabti, Babu J. N. Reddy, Rachid Rezgui, Wenqi Wang, Steven P. Gross & George T. Shubeita. (2022) The ubiquitous microtubule-associated protein 4 (MAP4) controls organelle distribution by regulating the activity of the kinesin motor. Proceedings of the National Academy of Sciences 119:41.
Crossref
Liyu Chen, Esteban Cruz, Lotta E. Oikari, Pranesh Padmanabhan, Jae Song & Jürgen Götz. (2022) Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound. Advanced Drug Delivery Reviews 189, pages 114517.
Crossref
Lone Helboe, Nina Rosenqvist, Christiane Volbracht, Lars Ø. Pedersen, Jan T. Pedersen, Søren Christensen, Jan Egebjerg, Claus T. Christoffersen, Benny Bang-Andersen, Thomas G. Beach, Geidy E. Serrano & Jeppe Falsig. (2022) Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer’s Disease and Primary Tauopathy Postmortem Brains. Journal of Alzheimer's Disease 88:1, pages 207-228.
Crossref
Shin-ichi Hisanaga, Ambika Krishnankutty & Taeko Kimura. (2022) In vivo analysis of the phosphorylation of tau and the tau protein kinases Cdk5-p35 and GSK3β by using Phos-tag SDS–PAGE. Journal of Proteomics 262, pages 104591.
Crossref
Shin-ichi Hisanaga, Ambika Krishnankutty & Taeko Kimura. (2022) Phos-tag SDS-PAGE analysis of <i>in vivo</i> phosphorylation of microtubule-associated protein tau and its protein kinase GSK3βPhos-tag電気泳動法による微小管結合タンパク質タウとタウキナーゼGSK3βの<i>in vivo</i>リン酸化解析. Electrophoresis Letters 66:1, pages 35-41.
Crossref
Olivier Nicole. 2022. Les Maladies Neurodégénératives et Maladies Apparentées en Pratique. Les Maladies Neurodégénératives et Maladies Apparentées en Pratique 17 28 .
Manisha Singh, Pranav Pancham, Shriya Agarwal, Harleen Kaur, Vinayak Agarwal, Raj Kumar Tiwari, Shalini Mani & Rachana. 2022. Current Thoughts on Dementia. Current Thoughts on Dementia 441 464 .
Nastaran Samimi, Govinda Sharma, Taeko Kimura, Tomoyasu Matsubara, Anni Huo, Kurumi Chiba, Yuko Saito, Shigeo Murayama, Hiroyasu Akatsu, Yoshio Hashizume, Masato Hasegawa, Mojtaba Farjam, Koorosh Shahpasand, Kanae Ando & Shin-ichi Hisanaga. (2021) Distinct phosphorylation profiles of tau in brains of patients with different tauopathies. Neurobiology of Aging 108, pages 72-79.
Crossref
Pattama Panmak, Chutikorn Nopparat, Kannika Permpoonpattana, Jatuporn Namyen & Piyarat Govitrapong. (2021) Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus. Neurochemistry International 148, pages 105121.
Crossref
Pragati & Surajit Sarkar. (2021) Shaggy functions downstream of dMyc and their concurrent downregulation confers additive rescue against tau toxicity in Drosophila . BioFactors 47:3, pages 461-477.
Crossref
Leonel Pereira & Ana Valado. (2021) The Seaweed Diet in Prevention and Treatment of the Neurodegenerative Diseases. Marine Drugs 19:3, pages 128.
Crossref
Monika Arbaciauskaite, Yu Lei & Yong Ku Cho. (2021) High-specificity antibodies and detection methods for quantifying phosphorylated tau from clinical samples. Antibody Therapeutics 4:1, pages 34-44.
Crossref
Abdullah Al Mamun & Md. Farhad Hossain. 2020. Quality Control of Cellular Protein in Neurodegenerative Disorders. Quality Control of Cellular Protein in Neurodegenerative Disorders 129 153 .
Andrea Renee Kelley, Stephan B.H. Bach & George Perry. (2019) Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865:8, pages 2040-2047.
Crossref
B. G. Adleyba, G. V. Gavrilov, A. V. Stanishevsky, B. V. Gaydar, D. V. Svistov, V. Yu. Lobzin & K. A. Kolmakova. (2019) Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus. Neurology, Neuropsychiatry, Psychosomatics 11:1, pages 53-58.
Crossref
Fayaz Ahmad Mir & Zaigham Abbas Rizvi. 2019. Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease. Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease 235 269 .
Caterina Giacomini, Chuay-Yeng Koo, Natalia Yankova, Ignatius A. Tavares, Selina Wray, Wendy Noble, Diane P. Hanger & Jonathan D. H. Morris. (2018) A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies. Acta Neuropathologica Communications 6:1.
Crossref
Heng Zhang, Xueyong Zhu, Gabriel Pascual, Jehangir S. Wadia, Elissa Keogh, Jeroen J. Hoozemans, Berdien Siregar, Hanna Inganäs, Esther J.M. Stoop, Jaap Goudsmit, Adrian Apetri, Wouter Koudstaal & Ian A. Wilson. (2018) Structural Basis for Recognition of a Unique Epitope by a Human Anti-tau Antibody. Structure 26:12, pages 1626-1634.e4.
Crossref
Rubayat Islam Khan, Saif Nirzhor & Barnaly Rashid. (2018) A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer’s Disease. Brain Sciences 8:9, pages 162.
Crossref
María J. Pérez, Claudia Jara & Rodrigo A. Quintanilla. (2018) Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration. Frontiers in Neuroscience 12.
Crossref
David Seynnaeve, Mara Vecchio, Gernot Fruhmann, Joke Verelst, Melody Cools, Jimmy Beckers, Daniel Mulvihill, Joris Winderickx & Vanessa Franssens. (2018) Recent Insights on Alzheimer’s Disease Originating from Yeast Models. International Journal of Molecular Sciences 19:7, pages 1947.
Crossref
Bettina M. Foidl & Christian Humpel. (2018) Differential Hyperphosphorylation of Tau-S199, -T231 and -S396 in Organotypic Brain Slices of Alzheimer Mice. A Model to Study Early Tau Hyperphosphorylation Using Okadaic Acid. Frontiers in Aging Neuroscience 10.
Crossref
Cyril Laurent, Luc Buée & David Blum. (2018) Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?. Biomedical Journal 41:1, pages 21-33.
Crossref
Amrita Ramkumar, Brigette Y. Jong & Kassandra M. Ori-McKenney. (2018) ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins. Developmental Dynamics 247:1, pages 138-155.
Crossref
Richard Rubenstein, Binggong Chang, Natalia Grinkina, Eleanor Drummond, Peter Davies, Meir Ruditzky, Deep Sharma, Kevin Wang & Thomas Wisniewski. (2017) Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein. Acta Neuropathologica Communications 5:1.
Crossref
Jong Kil Lee & Nam-Jung Kim. (2017) Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer’s Disease. Molecules 22:8, pages 1287.
Crossref
Taeko Kimura & Shinichi Hisanaga. (2017) Phos-tag SDS-PAGE analysis of complicated phosphorylation of a neurodegenerative disease protein tau. Electrophoresis Letters 61:2, pages 49-52.
Crossref
Mousa Alghazwi, Yen Qi Kan, Wei Zhang, Wei Ping Gai, Mary J. Garson & Scott Smid. (2016) Neuroprotective activities of natural products from marine macroalgae during 1999?2015. Journal of Applied Phycology 28:6, pages 3599-3616.
Crossref
Daniela I. Hirni, Sasa L. Kivisaari, Sabine Krumm, Andreas U. Monsch, Manfred Berres, Fatma Oeksuez, Julia Reinhardt, Stephan Ulmer, Reto W. Kressig, Christoph Stippich & Kirsten I. Taylor. (2016) Neuropsychological Markers of Medial Perirhinal and Entorhinal Cortex Functioning are Impaired Twelve Years Preceding Diagnosis of Alzheimer’s Dementia. Journal of Alzheimer's Disease 52:2, pages 573-580.
Crossref
Nicola J. Grant, Philip J. Coates, Yvonne L. Woods, Susan E. Bray, Nicholas A. Morrice, C. James Hastie, Douglas J. Lamont, Francis A. Carey & Calum Sutherland. (2015) Phosphorylation of a splice variant of collapsin response mediator protein 2 in the nucleus of tumour cells links cyclin dependent kinase-5 to oncogenesis. BMC Cancer 15:1.
Crossref
Maria Niures P.S. Matioli & Ricardo Nitrini. (2015) Mechanisms linking brain insulin resistance to Alzheimer's disease. Dementia & Neuropsychologia 9:2, pages 96-102.
Crossref
Sophie Sokolow, Kristen M. Henkins, Tina Bilousova, Bianca Gonzalez, Harry V. Vinters, Carol A. Miller, Lindsey Cornwell, Wayne W. Poon & Karen H. Gylys. (2015) Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease. Journal of Neurochemistry 133:3, pages 368-379.
Crossref
Katerina Papanikolopoulou & Efthimios M.C. Skoulakis. (2015) Temporally distinct phosphorylations differentiate Tau-dependent learning deficits and premature mortality in Drosophila. Human Molecular Genetics 24:7, pages 2065-2077.
Crossref
Alessandro Didonna & Federico Benetti. (2015) Post-translational modifications in neurodegeneration. AIMS Biophysics 3:1, pages 27-49.
Crossref
G. A. Grigor’yan. (2014) The Role of Glycogen Synthase Kinase 3 in the Mechanisms of Learning and Memory. Neuroscience and Behavioral Physiology 44:9, pages 1051-1058.
Crossref
Herv? Maurin, Benoit Lechat, Peter Borghgraef, Herman Devijver, Tomasz Jaworski & Fred Van Leuven. (2014) Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3?/?. European Journal of Neuroscience 40:2, pages 2442-2453.
Crossref
Ai-ling Hui, Yan Chen, Shi-jing Zhu, Chang-sheng Gan, Jian Pan & An Zhou. (2014) Design and synthesis of tacrine-phenothiazine hybrids as multitarget drugs for Alzheimer’s disease. Medicinal Chemistry Research 23:7, pages 3546-3557.
Crossref
Sandra Tenreiro, Katrin Eckermann & Tiago F. Outeiro. (2014) Protein phosphorylation in neurodegeneration: friend or foe?. Frontiers in Molecular Neuroscience 7.
Crossref
Marta Dobarro, Gorka Gerenu & María J Ramírez. (2013) Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice. International Journal of Neuropsychopharmacology 16:10, pages 2245-2257.
Crossref
Jisheng Nie, Lei Duan, Zhiwei Yan & Qiao Niu. (2013) Tau Hyperphosphorylation is Associated with Spatial Learning and Memory After Exposure to Benzo[a]pyrene in SD Rats. Neurotoxicity Research 24:4, pages 461-471.
Crossref
Annalisa Cavallini, Suzanne Brewerton, Amanda Bell, Samantha Sargent, Sarah Glover, Clare Hardy, Roger Moore, John Calley, Devaki Ramachandran, Michael Poidinger, Eric Karran, Peter Davies, Michael Hutton, Philip Szekeres & Suchira Bose. (2013) An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease. Journal of Biological Chemistry 288:32, pages 23331-23347.
Crossref
Harald Lund, Richard F. Cowburn, Elin Gustafsson, Kia Strömberg, Anne Svensson, Leif Dahllund, David Malinowsky & Dan Sunnemark. (2013) Tau-Tubulin Kinase 1 Expression, Phosphorylation and Co-Localization with Phospho-Ser422 Tau in the Alzheimer's Disease Brain. Brain Pathology 23:4, pages 378-389.
Crossref
Florence Clavaguera, Isabelle Lavenir, Ben Falcon, Stephan Frank, Michel Goedert & Markus Tolnay. (2013) ?Prion-Like? Templated Misfolding in Tauopathies. Brain Pathology 23:3, pages 342-349.
Crossref
Ignatius A. Tavares, Dona Touma, Steven Lynham, Claire Troakes, Megan Schober, Mirsada Causevic, Ritu Garg, Wendy Noble, Richard Killick, Istvan Bodi, Diane P. Hanger & Jonathan D.H. Morris. (2013) Prostate-derived Sterile 20-like Kinases (PSKs/TAOKs) Phosphorylate Tau Protein and Are Activated in Tangle-bearing Neurons in Alzheimer Disease. Journal of Biological Chemistry 288:21, pages 15418-15429.
Crossref
Yu Luo, Yun-Juan Nie, Hai-Rong Shi, Zhong-Fei Ni, Qun Wang, Jian-Zhi Wang & Gong-Ping Liu. (2013) PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1833:5, pages 1235-1243.
Crossref
Heather H. Shih, Chao Tu, Wei Cao, Anne Klein, Renee Ramsey, Brian J. Fennell, Matthew Lambert, Deirdre Ní Shúilleabháin, Bénédicte Autin, Eugenia Kouranova, Sri Laxmanan, Steven Braithwaite, Leeying Wu, Mostafa Ait-Zahra, Anthony J. Milici, Jo Ann Dumin, Edward R. LaVallie, Maya Arai, Christopher Corcoran, Janet E. Paulsen, Davinder Gill, Orla Cunningham, Joel Bard, Lydia Mosyak & William J.J. Finlay. (2012) An Ultra-specific Avian Antibody to Phosphorylated Tau Protein Reveals a Unique Mechanism for Phosphoepitope Recognition. Journal of Biological Chemistry 287:53, pages 44425-44434.
Crossref
Rory Johnson, Wendy Noble, Gian Gaetano Tartaglia & Noel J. Buckley. (2012) Neurodegeneration as an RNA disorder. Progress in Neurobiology 99:3, pages 293-315.
Crossref
Daniel Martins-de-Souza, Paul C. Guest, Natacha Vanattou-Saifoudine, Hassan Rahmoune & Sabine Bahn. (2012) Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function. European Archives of Psychiatry and Clinical Neuroscience 262:8, pages 657-666.
Crossref
Heela Sarlus, Caroline Olgart H?glund, Bianka Karshikoff, Xiuzhe Wang, Mats Lekander, Marianne Schultzberg & Mircea Oprica. (2012) Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation. Journal of Cellular and Molecular Medicine 16:10, pages 2401-2412.
Crossref
Yan WEI, Jun-Ye MIAO & Ying LIU. (2012) Endogenous and Exogenous Factors in Hyperphosphorylation of Tau in Alzheimer′s Disease*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 39:8, pages 778-784.
Crossref
Ritchie Williamson, Alison McNeilly & Calum Sutherland. (2012) Insulin resistance in the brain: An old-age or new-age problem?. Biochemical Pharmacology 84:6, pages 737-745.
Crossref
Isidro Ferrer. (2012) Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia. Progress in Neurobiology 97:1, pages 38-51.
Crossref
Kambiz N. Alavian, Steven I. Dworetzky, Laura Bonanni, Ping Zhang, Silvio Sacchetti, Maria A. Mariggio, Marco Onofrj, Astrid Thomas, Hongmei Li, Jamie E. Mangold, Armando P. Signore, Ulrike DeMarco, Damon R. Demady, Panah Nabili, Emma Lazrove, Peter J.S. Smith, Valentin K. Gribkoff & Elizabeth A. Jonas. (2012) Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency. Brain Research 1446, pages 1-11.
Crossref
Suzanne M. de la Monte. (2012) Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimerʼs Disease. Drugs 72:1, pages 49-66.
Crossref
Stephen D. Skaper. 2012. New Perspectives of Central Nervous System Injury and Neuroprotection. New Perspectives of Central Nervous System Injury and Neuroprotection 277 316 .
J.P. Cata, B. Abdelmalak & E. Farag. (2011) Neurological biomarkers in the perioperative period. British Journal of Anaesthesia 107:6, pages 844-858.
Crossref
Daniel Martins-de-Souza, Paul C. Guest, Natacha Vanattou-Saifoudine, Hendrik Wesseling, Hassan Rahmoune & Sabine Bahn. (2011) The need for phosphoproteomic approaches in psychiatric research. Journal of Psychiatric Research 45:10, pages 1404-1406.
Crossref
Alessia Usardi, Amy M. Pooler, Anjan Seereeram, C. Hugh Reynolds, Pascal Derkinderen, Brian Anderton, Diane P. Hanger, Wendy Noble & Ritchie Williamson. (2011) Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau. FEBS Journal 278:16, pages 2927-2937.
Crossref
Xiu-Qing Yao, Xiao-Xue Zhang, Yang-Yang Yin, Bin Liu, Dan-Ju Luo, Dan Liu, Ning-Ning Chen, Zhong-Fei Ni, Xiong Wang, Qun Wang, Jian-Zhi Wang & Gong-Ping Liu. (2011) Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. Biochemical Journal 437:2, pages 335-344.
Crossref
Stefano Benvegnù, Paola RoncagliaFederica Agostini, Cristina Casalone, Cristiano Corona, Stefano GustincichGiuseppe Legname. (2011) Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus. Physiological Genomics 43:12, pages 711-725.
Crossref
Guoyi Li, Ming Chang, Huiyi Jiang, Hongrong Xie, Zhong Dong & Linsen Hu. (2011) Proteomics analysis of methylglyoxal-induced neurotoxic effects in SH-SY5Y cells. Cell Biochemistry and Function 29:1, pages 30-35.
Crossref
Marc P. M. Soutar, Woo-Yang Kim, Ritchie Williamson, Mark Peggie, Charles James Hastie, Hilary McLauchlan, William D. Snider, Phillip R. Gordon-Weeks & Calum Sutherland. (2010) Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain. Journal of Neurochemistry 115:4, pages 974-983.
Crossref
Arnaud Leroy, Isabelle Landrieu, Isabelle Huvent, Dominique Legrand, Bernadette Codeville, Jean-Michel Wieruszeski & Guy Lippens. (2010) Spectroscopic Studies of GSK3β Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-terminal Domain of Apolipoprotein E. Journal of Biological Chemistry 285:43, pages 33435-33444.
Crossref
Diane P. HangerSelina Wray. (2010) Tau cleavage and tau aggregation in neurodegenerative disease. Biochemical Society Transactions 38:4, pages 1016-1020.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.